238 related articles for article (PubMed ID: 22125665)
21. Human apolipoprotein E4 alters the amyloid-beta 40:42 ratio and promotes the formation of cerebral amyloid angiopathy in an amyloid precursor protein transgenic model.
Fryer JD; Simmons K; Parsadanian M; Bales KR; Paul SM; Sullivan PM; Holtzman DM
J Neurosci; 2005 Mar; 25(11):2803-10. PubMed ID: 15772340
[TBL] [Abstract][Full Text] [Related]
22. Different effects of Alzheimer's peptide Aβ(1-40) oligomers and fibrils on supported lipid membranes.
Canale C; Seghezza S; Vilasi S; Carrotta R; Bulone D; Diaspro A; San Biagio PL; Dante S
Biophys Chem; 2013 Dec; 182():23-9. PubMed ID: 23998637
[TBL] [Abstract][Full Text] [Related]
23. Apolipoprotein E associated with reconstituted high-density lipoprotein-like particles is protected from aggregation.
Hubin E; Verghese PB; van Nuland N; Broersen K
FEBS Lett; 2019 Jun; 593(11):1144-1153. PubMed ID: 31058310
[TBL] [Abstract][Full Text] [Related]
24. Aβ42 oligomers, but not fibrils, simultaneously bind to and cause damage to ganglioside-containing lipid membranes.
Williams TL; Johnson BR; Urbanc B; Jenkins AT; Connell SD; Serpell LC
Biochem J; 2011 Oct; 439(1):67-77. PubMed ID: 21702743
[TBL] [Abstract][Full Text] [Related]
25. Quantification of molecular interactions between ApoE, amyloid-beta (Aβ) and laminin: Relevance to accumulation of Aβ in Alzheimer's disease.
Zekonyte J; Sakai K; Nicoll JA; Weller RO; Carare RO
Biochim Biophys Acta; 2016 May; 1862(5):1047-53. PubMed ID: 26327683
[TBL] [Abstract][Full Text] [Related]
26. The interaction of amyloid-beta with ApoE.
Carter DB
Subcell Biochem; 2005; 38():255-72. PubMed ID: 15709483
[TBL] [Abstract][Full Text] [Related]
27. Point mutations in Aβ result in the formation of distinct polymorphic aggregates in the presence of lipid bilayers.
Pifer PM; Yates EA; Legleiter J
PLoS One; 2011 Jan; 6(1):e16248. PubMed ID: 21267410
[TBL] [Abstract][Full Text] [Related]
28. Lipid homeostasis and apolipoprotein E in the development and progression of Alzheimer's disease.
Lane RM; Farlow MR
J Lipid Res; 2005 May; 46(5):949-68. PubMed ID: 15716586
[TBL] [Abstract][Full Text] [Related]
29. Astrocyte lipoproteins, effects of apoE on neuronal function, and role of apoE in amyloid-beta deposition in vivo.
Fagan AM; Holtzman DM
Microsc Res Tech; 2000 Aug; 50(4):297-304. PubMed ID: 10936884
[TBL] [Abstract][Full Text] [Related]
30. Characterization of the binding of amyloid-beta peptide to cell culture-derived native apolipoprotein E2, E3, and E4 isoforms and to isoforms from human plasma.
Yang DS; Smith JD; Zhou Z; Gandy SE; Martins RN
J Neurochem; 1997 Feb; 68(2):721-5. PubMed ID: 9003062
[TBL] [Abstract][Full Text] [Related]
31. ApoE and Abeta1-42 interactions: effects of isoform and conformation on structure and function.
Manelli AM; Stine WB; Van Eldik LJ; LaDu MJ
J Mol Neurosci; 2004; 23(3):235-46. PubMed ID: 15181252
[TBL] [Abstract][Full Text] [Related]
32. APOE regulates the transport of GM1.
Zhang DY; Wang J; Huang G; Langberg S; Ding F; Dokholyan NV
bioRxiv; 2024 Apr; ():. PubMed ID: 38617316
[TBL] [Abstract][Full Text] [Related]
33. Preparation protocols of aβ(1-40) promote the formation of polymorphic aggregates and altered interactions with lipid bilayers.
Yates EA; Legleiter J
Biochemistry; 2014 Nov; 53(45):7038-50. PubMed ID: 25349919
[TBL] [Abstract][Full Text] [Related]
34. A dual role for apolipoprotein e in neuroinflammation: anti- and pro-inflammatory activity.
Guo L; LaDu MJ; Van Eldik LJ
J Mol Neurosci; 2004; 23(3):205-12. PubMed ID: 15181248
[TBL] [Abstract][Full Text] [Related]
35. Murine versus human apolipoprotein E4: differential facilitation of and co-localization in cerebral amyloid angiopathy and amyloid plaques in APP transgenic mouse models.
Liao F; Zhang TJ; Jiang H; Lefton KB; Robinson GO; Vassar R; Sullivan PM; Holtzman DM
Acta Neuropathol Commun; 2015 Nov; 3():70. PubMed ID: 26556230
[TBL] [Abstract][Full Text] [Related]
36. Human ApoE Isoforms Differentially Modulate Glucose and Amyloid Metabolic Pathways in Female Brain: Evidence of the Mechanism of Neuroprotection by ApoE2 and Implications for Alzheimer's Disease Prevention and Early Intervention.
Keeney JT; Ibrahimi S; Zhao L
J Alzheimers Dis; 2015; 48(2):411-24. PubMed ID: 26402005
[TBL] [Abstract][Full Text] [Related]
37. Apolipoprotein E, especially apolipoprotein E4, increases the oligomerization of amyloid β peptide.
Hashimoto T; Serrano-Pozo A; Hori Y; Adams KW; Takeda S; Banerji AO; Mitani A; Joyner D; Thyssen DH; Bacskai BJ; Frosch MP; Spires-Jones TL; Finn MB; Holtzman DM; Hyman BT
J Neurosci; 2012 Oct; 32(43):15181-92. PubMed ID: 23100439
[TBL] [Abstract][Full Text] [Related]
38. Apolipoprotein E (ApoE) isoform-dependent lipid release from astrocytes prepared from human ApoE3 and ApoE4 knock-in mice.
Gong JS; Kobayashi M; Hayashi H; Zou K; Sawamura N; Fujita SC; Yanagisawa K; Michikawa M
J Biol Chem; 2002 Aug; 277(33):29919-26. PubMed ID: 12042316
[TBL] [Abstract][Full Text] [Related]
39. Abca1 deficiency affects Alzheimer's disease-like phenotype in human ApoE4 but not in ApoE3-targeted replacement mice.
Fitz NF; Cronican AA; Saleem M; Fauq AH; Chapman R; Lefterov I; Koldamova R
J Neurosci; 2012 Sep; 32(38):13125-36. PubMed ID: 22993429
[TBL] [Abstract][Full Text] [Related]
40. Levels of soluble apolipoprotein E/amyloid-β (Aβ) complex are reduced and oligomeric Aβ increased with APOE4 and Alzheimer disease in a transgenic mouse model and human samples.
Tai LM; Bilousova T; Jungbauer L; Roeske SK; Youmans KL; Yu C; Poon WW; Cornwell LB; Miller CA; Vinters HV; Van Eldik LJ; Fardo DW; Estus S; Bu G; Gylys KH; Ladu MJ
J Biol Chem; 2013 Feb; 288(8):5914-26. PubMed ID: 23293020
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
